e-learning
resources
Glasgow 2004
Monday 06.09.2004
Pathogenesis of OSA
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Does chronic opioid therapy alter the pattern of sleep apnea?
J. M. Walker, R. J. Farney, K. M. Boyle, T. V. Cloward, K. C. Shilling (Salt Lake City, United States Of America)
Source:
Annual Congress 2004 - Pathogenesis of OSA
Session:
Pathogenesis of OSA
Session type:
Poster Discussion
Number:
2752
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. M. Walker, R. J. Farney, K. M. Boyle, T. V. Cloward, K. C. Shilling (Salt Lake City, United States Of America). Does chronic opioid therapy alter the pattern of sleep apnea?. Eur Respir J 2004; 24: Suppl. 48, 2752
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Static lung volumes and spirometry measurements
Panel discussion: The role of pharmacotherapy connected to OSA pathophysiological traits
Expert interview ERS guideline on non-CPAP therapies in obstructive sleep apnoea
Related content which might interest you:
Refractory sleep disordered breathing associated with chronic opioid therapy
Source: Eur Respir J 2001; 18: Suppl. 33, 88s
Year: 2001
Concomitant benzodiazepine and opioids decrease sleep apnoea risk in chronic pain patients
Source: ERJ Open Res, 6 (3) 00093-2020; 10.1183/23120541.00093-2020
Year: 2020
Does CPAP therapy affect motor cortical excitability in patients with obstructive sleep apnea syndrome (OSAS)?
Source: Annual Congress 2004 - CPAP therapy for OSA
Year: 2004
The role of pharmacological treatments in sleep apnoea syndrome
Source: Annual Congress 2004 - What's new in the treatment of sleep apnoea
Year: 2004
Reported but not measured sleep latency predicts successful CPAP therapy in patients with obstructive sleep apnoea
Source: Eur Respir J 2002; 20: Suppl. 38, 101s
Year: 2002
Atypical patterns in portable monitoring for sleep apnoea: features of nocturnal epilepsy?
Source: Eur Respir J 2013; 41: 368-375
Year: 2013
Night treatment with long acting ß2 agonists in mild COPD patients with sleep apnoea syndrome
Source: Eur Respir J 2007; 30: Suppl. 51, 74s
Year: 2007
Can leptin be used to treat obstructive sleep apnoea?
Source: International Congress 2019 – New horizons for pharmacotherapy of sleep-disordered breathing: from bench to bedside
Year: 2019
Daytime sleepiness in patients on intrathecal chronic opioid (IT) therapy is not related to sleep disordered breathing (SDB)
Source: Annual Congress 2011 - Comorbid obstructive sleep apnoea (OSA) and OSA comorbidities
Year: 2011
Insomnia related to sleep apnoea: effect of long-term auto-adjusting positive airway pressure treatment
Source: Eur Respir J 2013; 41: 593-600
Year: 2013
Positional therapy for obstructive sleep apnea: do your patients use it at home?
Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea
Year: 2009
The influence of long-term CPAP therapy on metabolic variables in obstructive sleep apnea patients
Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing
Year: 2018
Clinical implications of residual sleep apnoea after chronic CPAP therapy
Source: Breathe 2011; 7: 289-290
Year: 2011
The use of beta-blockers is not associated with increased daytime sleepiness in patients with obstructive sleep apnoea
Source: International Congress 2019 – Beyond continuous positive airway pressure treatment
Year: 2019
Role of common hypnotics on the phenotypic causes of obstructive sleep apnoea: paradoxical effects of zolpidem
Source: Eur Respir J, 50 (6) 1701344; 10.1183/13993003.01344-2017
Year: 2017
Varenicline administration for smoking cessation may reduce apnea hypnea index in sleep apnea patients
Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing
Year: 2021
Return of sleep apnoea and sleep fragmentation following CPAP withdrawal in patients with obstructive sleep apnoea
Source: Eur Respir J, 53 (5) 1802351; 10.1183/13993003.02351-2018
Year: 2019
Compliance in sleep apnoea therapy: influence of home care support and pressure mode
Source: Eur Respir J 2009; 33: 804-811
Year: 2009
The effect of concomitant COPD on obstructive sleep apnea syndrome severity and sleep structure
Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept